Aspire Biopharma Warrant (ASBPW)

• Market cap: $483K
• 1 day: -9.09%
• 5 days: -35.48%
• 1 month: 40.85%
• 3 months: 36.05%
• 6 months: 13.64%
• Year to date: 7.53%
• 1 year: -55.26%
• 5 years: -94.29%
• 10 years: -94.29%
• Sector: Healthcare
• Industry: Biotechnology

About: Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.